1. First evidence on the role of palmitoylethanolamide in energy homeostasis in fish.
- Author
-
Gómez-Boronat M, Isorna E, Conde-Sieira M, Delgado MJ, Soengas JL, and de Pedro N
- Subjects
- Amides, Animals, Body Weight drug effects, CLOCK Proteins genetics, CLOCK Proteins metabolism, Eating drug effects, Eating physiology, Ethanolamines administration & dosage, Gene Expression Regulation drug effects, Hypothalamus drug effects, Hypothalamus metabolism, Injections, Intraperitoneal, Leptin metabolism, Lipid Metabolism drug effects, Liver drug effects, Liver metabolism, Locomotion drug effects, Locomotion physiology, Palmitic Acids administration & dosage, Peroxisome Proliferator-Activated Receptors genetics, Peroxisome Proliferator-Activated Receptors metabolism, Weight Gain drug effects, Energy Metabolism drug effects, Ethanolamines pharmacology, Goldfish metabolism, Homeostasis drug effects, Palmitic Acids pharmacology
- Abstract
The objective of this study was to investigate the role of palmitoylethanolamide (PEA) in the regulation of energy homeostasis in goldfish (Carassius auratus). We examined the effects of acute or chronic intraperitoneal treatment with PEA (20 μg·g
-1 body weight) on parameters related to food intake and its regulatory mechanisms, locomotor activity, glucose and lipid metabolism, and the possible involvement of transcription factors and clock genes on metabolic changes in the liver. Acute PEA treatment induced a decrease in food intake at 6 and 8 h post-injection, comparable to that observed in mammals. This PEA anorectic effect in goldfish could be mediated through interactions with leptin and NPY, as PEA increased hepatic expression of leptin aI and reduced hypothalamic expression of npy. The PEA chronic treatment reduced weight gain, growth rate, and locomotor activity. The rise in glycolytic potential together with the increased potential of glucose to be transported into liver suggests an enhanced use of glucose in the liver after PEA treatment. In addition, part of glucose may be exported to be used in other tissues. The activity of fatty acid synthase (FAS) increased after chronic PEA treatment, suggesting an increase in the hepatic lipogenic capacity, in contrast with the mammalian model. Such lipogenic increment could be linked with the PEA-induction of REV-ERBα and BMAL1 found after the chronic treatment. As a whole, the present study shows the actions of PEA in several compartments related to energy homeostasis and feeding behavior, supporting a regulatory role for this N-acylethanolamine in fish., (Copyright © 2019 Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF